Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-21 2:52:4 pm | GlycoMimetics Can Become A Game Changer In Blood Cancers | SeekingAlpha |
| 2024-03-21 5:50:0 am | Should You Buy GlycoMimetics (GLYC) Ahead of Earnings? | Zacks |
| 2024-03-13 4:0:0 am | GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024 | Business Wire |
| 2024-03-04 6:42:8 am | Positive Signs As Multiple Insiders Buy GlycoMimetics Stock | Simply Wall St. |
| 2024-02-26 4:0:0 am | GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference | Business Wire |
| 2024-02-12 4:0:0 am | GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Business Wire |
| 2024-01-04 4:0:0 am | GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687 | Business Wire |
| 2024-01-03 4:0:0 am | Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information